Kimoks

Moxifloxacin, the active ingredient in Kimoks, is a fluoroquinolone antibiotic presented as an oral dosage form for the treatment of bacterial infections such as pneumonia, sinusitis, bronchitis and skin infections. It is used in adult patients when a broad‑spectrum antibacterial is required.

GNH USA supplies Kimoks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is indicated for bacterial infections affecting the respiratory and skin systems.

Community‑acquired pneumonia: effective treatment of infection caused by susceptible organisms. Acute bacterial sinusitis: eradicates the causative bacteria and relieves sinus inflammation. Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and improves respiratory symptoms. Skin and soft tissue infections: combats susceptible gram‑positive and gram‑negative pathogens.

Moxifloxacin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional sense of light‑headedness. - Rash: mild skin erythema. - Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects: - Tendon rupture: especially in older adults or those on corticosteroids. - QT interval prolongation: may predispose to cardiac arrhythmias. - Severe hypersensitivity: including Stevens‑Johnson syndrome. - Clostridioides difficile colitis: risk of severe intestinal infection. - Peripheral neuropathy: persistent sensory disturbances. - Hepatotoxicity: rare but significant liver injury.

Before prescribing Moxifloxacin, consider patient history and potential risk factors.

Assess cardiac risk: avoid in patients with known QT prolongation. Avoid use in patients with a history of tendon disorders. Monitor renal and hepatic function in patients with organ impairment. Use with caution in pregnant or breastfeeding women; safety data are limited. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Moxifloxacin can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of moxifloxacin. - Warfarin: may increase anticoagulant effect and bleeding risk. - Drugs that prolong QT interval (e.g., quinidine, amiodarone): heighten risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of CNS stimulation. - Corticosteroids: may raise the chance of tendon rupture. - Theophylline: may increase plasma concentrations and side effects.